Evidence map›Paper›PMID 42137621›Full record

ArticleFrontiers in bioengineering and biotechnology2026

AI-driven biomimetic design: sustainable bio-materials for eco-friendly aesthetic solutions.

Jia Yong

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jia YongSchool of Art, Liuzhou Polytechnic University, Liuzhou, Guangxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The exploration of bio-inspired art design using sustainable biomaterials has gained significant attention due to the increasing demand for environmentally responsible artistic practices. Traditional methods often focus on either aesthetic innovation or environmental sustainability, but rarely achieve a harmonious integration of both. This paper introduces the Eco-Causal Design Synthesizer, a novel framework that addresses this gap by integrating three pivotal modules: the Constraint-Aware Material Optimizer, the Agent-Driven Aesthetic Planner, and the Probabilistic Sustainability Evaluator. Methods: These modules work in synergy to optimize material selection, aesthetic planning, and sustainability evaluation, ensuring a balance between artistic creativity and ecological responsibility. The framework is further refined through two strategic innovations: Causal Constraint Modeling, which elucidates the interdependencies between material properties, design features, and sustainability metrics, and Synergistic Causal-Uncertainty Integration, which employs probabilistic methods to manage variability in biomaterial properties and environmental conditions. Results and Discussion: Experimental results demonstrate that the proposed methodology significantly enhances the eco-friendliness of art designs while maintaining high aesthetic standards. The implications of this research are profound, offering a comprehensive solution for artists and designers seeking to align their creative processes with sustainability objectives. By leveraging bio-inspired principles and advanced optimization techniques, this framework not only contributes to the field of sustainable art design but also sets a precedent for future research in eco-friendly artistic innovation.

Indexed as

agent-driven aesthetic planningbio-inspired art designeco-causal design synthesizersustainable biomaterialsuncertainty-aware sustainability evaluation

Identifiers

PMID42137621
PMCPMC13168009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.